Waypoint Bio raises $20M for AI-validated cell therapies
Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
Cell therapy News and Analysis
1 verified stories covering Cell therapy, product updates and industry developments.